---  
layout: startup_page  
title: "Egle Therapeutics"  
id: "egletx.com"  
permalink: "/egletherapeuticsegletx.com03172025/"  
website: "https://www.egle-tx.com"  
funding_round: ""  
funding_amount: "€9.3M"  
investors: "Bpifrance"  
about: "Egle Therapeutics is a clinical-stage biotechnology company specializing in immunomodulation, developing novel approaches to modulate regulatory T cell (Treg) activity for cancer and autoimmune diseases. They have developed a proprietary translational platform to identify Treg targets and develop antibody-based candidate drugs. Their lead candidate, EGL-001, is in a Phase I/II clinical trial."  
markets: "Biotech, Therapeutics, Oncology, Autoimmune Diseases"  
hq: "Paris, France"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/egle-tx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/egle-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/439329-25"  

date_display: "17-Mar-2025"  
date: "2025-03-17"

# SEO Optimization  
meta_title: "Egle Therapeutics -  Funding (€9.3M)"  
meta_description: "Egle Therapeutics, Egle Therapeutics is a clinical-stage biotechnology company specializing in immunomodulation, developing novel approaches to modulate regulatory T cel..."  
meta_keywords: "Egle Therapeutics, Biotech, Therapeutics, Oncology, Autoimmune Diseases,  funding"  
canonical_url: "https://startup.projectstartups.com/egletherapeuticsegletx.com03172025/"  
---